{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:04Z","timestamp":1790691364033,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-6368-8","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T14:02:56Z","timestamp":1575640976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of [64Cu][Cu(ATSM)] PET\/CT in the evaluation of hypoxia in a patient with Glioblastoma: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-4375","authenticated-orcid":false,"given":"Vincenzo","family":"Gangemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mignogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Guzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Lavano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Bongarzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Lucio","family":"Cascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"issue":"Suppl 2","key":"6368_CR1","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","volume":"15","author":"QT Ostrom","year":"2013","unstructured":"Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neuro-Oncology. 2013;15(Suppl 2):ii1\u201356.","journal-title":"Neuro-Oncology"},{"key":"6368_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11910-005-0047-7","volume":"5","author":"R Stupp","year":"2005","unstructured":"Stupp R, van den Bent MJ, Hegi ME. Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep. 2005;5:198\u2013206.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6368_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/annonc\/mdi834","volume":"16","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Beuf MJ. Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma. Ann Oncol. 2005;16:949.","journal-title":"Ann Oncol"},{"issue":"4","key":"6368_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/cells6040045","volume":"6","author":"Ana Monteiro","year":"2017","unstructured":"Monteiro AR, Hill R, Pilkington GJ, Madureira PA. The role of hypoxia in Glioblastoma invasion. Cells. 2017;6:45.","journal-title":"Cells"},{"key":"6368_CR5","first-page":"365","volume":"4","author":"E Lopci","year":"2014","unstructured":"Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, et al. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence. Am J Nucl Med Mol Imaging. 2014;4:365\u201384.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"6368_CR6","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1259\/bjr\/82292521","volume":"84","author":"I Mendichovszky","year":"2011","unstructured":"Mendichovszky I, Jackson A. Imaging hypoxia in gliomas. Br J Radiol. 2011;84:S145\u201358.","journal-title":"Br J Radiol"},{"key":"6368_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncoscience.311","volume":"3","author":"A Rios","year":"2016","unstructured":"Rios A, Hsu SH, Blanco A, Buryanek J, Day AL, McGuire MF, Brown RE. Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide. Oncoscience. 2016;3:156\u201363.","journal-title":"Oncoscience"},{"issue":"Suppl 5","key":"6368_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","volume":"9","author":"P Vaupel","year":"2004","unstructured":"Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9(Suppl 5):10\u20137.","journal-title":"Oncologist"},{"key":"6368_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00259-014-2714-x","volume":"41","author":"A Hino-Shishikura","year":"2014","unstructured":"Hino-Shishikura A, Tateishi U, Shibata H, Yoneyama T, Nishii T, Torii I, et al. Tumor hypoxia and microscopic diffusion capacity in brain tumors: a comparison of (62)cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET\/CT and diffusion-weighted MR imaging. Eur J Nucl Med Mol Imaging. 2014;41:1419\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6368_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3174\/ajnr.A3159","volume":"34","author":"K Tateishi","year":"2013","unstructured":"Tateishi K, Tateishi U, Sato M, Yamanaka S, Kanno H, Murata H, Inoue T, Kawahara N. Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma. AJNR Am J Neuroradiol. 2013;34:92\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"6368_CR11","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","volume":"14","author":"AM Spence","year":"2008","unstructured":"Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, et al. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res. 2008;14:2623\u201330.","journal-title":"Clin Cancer Res"},{"key":"6368_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.semnuclmed.2014.10.003","volume":"45","author":"SE Lapi","year":"2015","unstructured":"Lapi SE, Lewis JS, Dehdashti F. Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone). Semin Nucl Med. 2015;45:177\u201385.","journal-title":"Semin Nucl Med"},{"key":"6368_CR13","first-page":"58","volume":"2","author":"M Colombie","year":"2015","unstructured":"Colombie M, Gouard S, Frindel M, Vidal A, Cherel M, Kraeber-Bodere F, Rousseau C. Bourgeois M focus on the controversial aspects of (64)cu-ATSM in Tumoral hypoxia mapping by PET imaging. Front Med (Lausanne). 2015;2:58.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"6368_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3171\/2011.5.JNS101954","volume":"115","author":"Jason P. Sheehan","year":"2011","unstructured":"Sheehan JP, Popp B, Monteith S, Toulmin S, Tomlinson J, Martin J, Cifarelli CP, Lee DH, Park DM Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor. J Neurosurg 2011;115:749-753.","journal-title":"Journal of Neurosurgery"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6368-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T20:27:09Z","timestamp":1612988829000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6368-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6368"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6368-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the case patient for publication of this report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1197"}}